Dormicum 7.5mg Tablets contain Midazolam, a short-acting benzodiazepine with sedative and hypnotic properties. It is used for short-term treatment of insomnia and for sedation before certain surgical or diagnostic procedures, according to a doctor's prescription and medical supervision.
Dormicum 7.5mg Tablets contain Midazolam, a short-acting benzodiazepine that produces sedative, hypnotic and anxiolytic effects by enhancing the activity of GABA in the central nervous system. The medicine has a rapid onset and relatively short duration of action and is used in appropriate clinical situations such as short-term treatment of severe insomnia and sedation before certain surgical or diagnostic procedures. Dormicum 7.5mg should be used only according to a qualified healthcare professional's prescription because it can cause significant drowsiness, impaired coordination and reduced alertness.
Each Dormicum 7.5mg tablet contains Midazolam 7.5mg as Midazolam Maleate BP. The tablet also contains approved pharmaceutical excipients required for its formulation.
Take Dormicum 7.5mg exactly as prescribed by your doctor. Swallow the tablet with water and use it only for the prescribed duration. Because Midazolam can cause marked drowsiness, impaired concentration and reduced coordination, do not drive, operate machinery or perform activities requiring full alertness after taking it unless your doctor confirms that it is safe to do so. Avoid alcohol and do not combine Dormicum with other sedative medicines unless specifically directed by your doctor.
Dormicum 7.5mg is a tablet containing Midazolam 7.5mg, a short-acting benzodiazepine with sedative and hypnotic properties.
Dormicum 7.5mg is used for short-term treatment of certain severe sleep disturbances and for sedation before some surgical or diagnostic procedures, according to medical advice.
The active ingredient is Midazolam, with each tablet containing 7.5mg of Midazolam as Midazolam Maleate.
Midazolam enhances the effects of GABA, an inhibitory neurotransmitter in the brain. This produces calming, sedative and hypnotic effects.
Midazolam has hypnotic properties and may be prescribed for short-term treatment of insomnia in appropriate patients. It should not be used for prolonged or unsupervised treatment of sleep problems.
Yes. Midazolam may be used as premedication and sedation before certain surgical or diagnostic procedures.
Midazolam is characterized by a relatively rapid onset of action. The exact onset can vary depending on the individual and the circumstances of use.
Dormicum should only be taken according to your doctor's prescription. Long-term or unsupervised use of benzodiazepines is not recommended because of the risk of dependence and other adverse effects.
No. Alcohol can increase the sedative effects of Midazolam and may increase the risk of excessive sedation and breathing problems. Avoid alcohol while using this medicine.
No driving or operating machinery should be undertaken while the medicine is affecting alertness, coordination or concentration. Follow your doctor's instructions regarding when it is safe to resume these activities.
Do not combine Dormicum with other sedatives, sleeping medicines, opioids or medicines that depress the central nervous system unless your doctor specifically prescribes the combination.
The Pakistan product literature lists Dormicum 7.5mg tablets in a 10-tablet pack.
Store Dormicum below 30°C and protect it from light, heat and moisture. Keep the medicine out of the reach of children.
Yes, Dormicum 7.5mg tablets are listed by Pakistani pharmacies and are marketed by Martin Dow Pharmaceuticals (Pak) Ltd. Current stock can vary between pharmacies.
Yes. Martin Dow's product literature states that Dormicum tablets are to be sold on prescription of a registered medical practitioner only.
Customers Reviews For Dormicum (Midazolam) 7.5mg Tablets In Pakistan